Trial Profile
A study of efficacy of 177Lu-J591 in patients with castration-resistant prostate cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Aug 2015
Price :
$35
*
At a glance
- Drugs J 591 (Primary) ; J 591-radiolabelled (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics; Therapeutic Use
- 12 Aug 2015 New trial record